Role of epithelial-mesenchymal transition in tumor progression;Rôle de la transition épithélio-mésenchymateuse au cours de la progression tumorale

Bulletin de l'Academie Nationale de Medecine

Volumn 193, Issue 9, 2009, Pages 2017-2034

  Puisieux, Alain ^a,b,c  

^a CENTRE LÉON BÉRARD   (France)

^b INSERM   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Aging; Apoptosis; Neoplasm metastasis; Neoplasms

Indexed keywords

EID: 77954529686     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32376-3     Document Type: Article

References (50)

1. HANAHAN D., WEINBERG R.A. - The hallmarks of cancer. Cell, 2000, 100, 57-70.
2. FOLKMAN J. - Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 1971, 285, 1182-1186.
3. GEIGER T.R., PEEPER D.S. - Metastasis mechanisms. Biochim. Biophys. Acta., 2009, 1796, 293-308.
4. FUKUMURA D., XAVIER R., SUGIURA T. et al. - Tumor induction of VEGF promoter activity in stromal cells. Cell, 1998, 94, 715-725.
5. CAHILL D.P., KINZLER K.W., VOGELSTEIN B. et al. - Genetic instability and darwinian selection in tumours. Trends Cell Biol., 1999, 9, M57-M60.
6. MCGOWAN P.M., KIRSTEIN J.M., CHAMBERS A.F. - Micrometastatic disease and metastatic outgrowth: clinical issues and experimental approaches. Future Oncol., 2009, 5, 1083-1098.
7. THIERY J.P., SLEEMAN J.P. - Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell. Biol., 2006, 7, 131-142.
8. NAKAYA Y., SHENG G. - Epithelial to mesenchymal transition during gastrulation: an embryological view. Dev. Growth Differ.. 2008, 50, 755-766.
9. IWANO M., PLIETH D., DANOFF T.M. et al. - Evidence that fibroblasts derive from epithelium during tissue fibrosis. J. Clin. Invest., 2002, 110, 341-350.
10. BERX G., RASPE E., CHRISTOFORI G. - Pre-EMTing metastasis? Recapitulation of morphogenetic processes in cancer. Clin. Exp. Metastasis, 2007, 24, 587-597.
11. ZAVADIL J., BOTTINGER E.P. - TGF-beta and epithelial-to-mesenchymal transitions. Oncogene, 2005, 24, 5764-5774.
12. PEINADO H., QUINTANILLA M., CANO A. - Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J. Biol. Chem., 2003, 278, 21113-21123.
13. LOGAN C.Y., NUSSE R. The Wnt signaling pathway in development and disease. Annu. Rev. Cell. Dev. Biol., 2004, 20, 781-810. (Pubitemid 39488658)
14. PEINADO H., OLMEDA D., CANO A. - Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer, 2007, 7, 415-428.
15. CANNITO S, NOVO E, COMPAGNONE A, et al. - Redox mechanisms switch on hypoxiadependent epithelial-mesenchymal transition in cancer cells. Carcinogenesis, 2008, 29, 2267-2278.
16. YANG M.H., Wu M.Z., Cmou S.H., et al. - Direct regulation of TWIST by HIF-lalpha promotes metastasis. Nat. Cell. Biol., 2008, 10, 295-305.
17. PUISIEUX A., VALSESIA-WITTMANN S., ANSIEAU S. - A twist for survival and cancer progression. Br. J. Cancer, 2006, 94, 13-17.
18. ANSIEAU S., BASTED J., DOREAU A. et al. - Induction of EMT by twist proteins as a collateral effect of tumor-promoting inactivation of premature senescence. Cancer Cell, 2008 ; 14,79-89.
19. YANG J., WEINBERG R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell, 2008, 14, 818-829. (Pubitemid 351757205)
20. YANG J., MANI S.A., DONAHER J.L. et al. - Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 2004, 117, 927-939.
21. MATSUO N., SHIRAHA H., FUJIKAWA T. et al. - Twist expression promotes migration and invasion in hepatocellular carcinoma. BMC Cancer, 2009, 9, 240.
22. OKA H., SHIOZAKI H., KOBAYASHI K. et al. - Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res., 1993, 53, 1696-1701.
23. HIRATA T., FUKUSE T., NAIKI H. et al. Expression of E-cadherin and lymph node metastasis in resected non-small-cell lung cancer. Clin. Lung Cancer, 2001, 3, 134-140. (Pubitemid 33138778)
24. KAMARA T., KUSAKA T., Nism M. et al. - Dedifferentiation and decreased expression of adhesion molecules, E-cadherin and ZO-1, in colorectal cancer are closely related to liver metastasis. J. Exp. Clin. Cancer Res., 2003, 22, 117-123.
25. ONDER T.T., GUPTA P.B., MANI S.A. et al. - Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008, 68, 3645-3654.
26. TARIN D., THOMPSON E.W., NEWGREEN D.F. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res., 2005, 65, 5996-6000. (Pubitemid 40994379)
27. SPADERNA S., SCHMALHOFER O., HLUBEK F. et al. - A transient, EMT-linked loss of basement membranes indicates metastasis and poor survival in colorectal cancer. Gastroenterology, 2006, 131, 830-840.
28. TRIMBOLI A.J., FUKEMO K., DE BA. et al. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res., 2008, 68, 937-945. (Pubitemid 351206773)
29. LOWE S.W., CEPERO E., EVAN G. - Intrinsic tumour suppression. Nature. 2004, 432, 307-315.
30. VOUSDEN K.H., LANE D.P. - p53 in health and disease. Nat. Rev. Mol. Cell. Biol, 2007, 8, 275-283.
31. EVAN G.I., WYLLIE A.H., GILBERT C.S. et al. - Induction of apoptosis in fibroblasts by c-myc protein. Cell, 1992, 69, 119-128.
32. EISCHEN C.M., WEBER J.D., ROUSSEL M.F. - Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes Dev., 1999, 13, 2658-2669.
33. SERRANO M., LIN A.W., MCCURRACH M.E. et al. - Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell, 1997, 88, 593-602.
34. VALSESIA-WITTMANN S., MAGDELEINE M., DUPASQUIER S. et al. - Oncogenic cooperation between H-Twist and N-Myc overrides failsafe programs in cancer cells. Cancer Cell, 2004, 6, 625-630.
35. BRODEUR G.M., SEEGER R.C., SCHWAB M. et al. - Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science, 1984, 224, 1121-1124.
36. MAESTRO R., DEI Tos A.P., HAMAMORI Y. et al. - Twist is a potential oncogene that inhibits apoptosis. Genes Dev., 1999, 13, 2207-2217.
37. STASINOPOULOS I.A., MIRONCHIK Y., RAMAN A. el al. - HOXA5-twist interaction alters p53 homeostasis in breast cancer cells. J. Biol Chem., 2005, 280, 2294-2299.
38. SHIOTA M., IZUMI H., ONITSUKA T. et al. - Twist and p53 reciprocally regulate target genes via direct interaction. Oncogene, 2008.
39. GORGOULIS V.G., VASSILIOU L.V., KARAKAIDOS P. et al. - Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature, 2005, 434, 907-913.
40. BARTKOVA J., REZAEI N., LIONTOS M. et al. - Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature, 2006, 444, 633-637.
41. COLLADO M., GIL J., EFEYAN A. et al. - Tumour biology: senescence in premalignant tumours. Nature, 2005, 436, 642.
42. SARKISIAN C.J., KEISTER B.A., STAIRS D.B. et al. - A. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis. Nat. Cell. Biol. 2007, 9, 493-505.
43. MICHALOGLOU C., VREDEVELD L.C., SOENGAS M.S. et al. -BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature, 2005, 436, 720-724. (Pubitemid 41117276)
44. CHEN Z., TROTMAN L.C., SHAFFER D. et al. - Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature, 2005, 436, 725-730.
45. HUSEMANN Y., GEIGL J.B., SCHUBERT F. et al. Systemic spread is an early step in breast cancer. Cancer Cell, 2008, 13, 58-68. (Pubitemid 350309740)
46. MARION R.M., STRATI K., LI H. et al. - A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature, 2009, 460, 1149-1153.
47. MOREL A.P., LIEVRE M., THOMAS C et al. - Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS ONE, 2008, 3, e2888.
48. MANI S.A., GUO W., LIAO M.J. et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 2008, 133, 704-715. (Pubitemid 351636299)
49. CRHGHTON C.J., LI X., LANDIS M. et al. - Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proc. Natl. Acad. Sci. U S A. 2009, 106, 13820-13825.
50. GUPTA P.B., ONDER T.T., JIANG G. et al. - Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell., 2009, 138, 645-659.